Sinopharm ideal for children according to Sri Lankan virology expert

Xinhua News Agency

COLOMBO – According to Sri Lankan virology expert Prof. Tissa Vitarana, China’s Sinopharm vaccine is ideal for children since it is an inactivated vaccine.

Sri Lankan Prime Minister Mahinda Rajapaksa said in August that the government would soon begin vaccination of children over 12 years old. Local experts have been debating over the best vaccine to administer to young children.

“We must first do a pilot project with a random sample encompassing different groups, after looking at the data. We should see if antibodies are formed and if there are any side effects. My opinion is based on the scientific method and I think Sinopharm is the best for children,” Vitarana was quoted by local daily The Island as saying.

Vitarana is a graduate of the University of London and was head of the Medical Research Institute of Sri Lanka from 1983 to 1994.

Sri Lanka has so far fully vaccinated over 50 percent of its population. Vaccinations are currently open to all adults over the age of 18. (Xinhua) – bny

Popular

PBBM not pushing Charter change for term extension

By Ruth Abbey Gita-Carlos | Philippine News Agency Malacañang on Tuesday dismissed as mere speculation the claims that President Ferdinand R. Marcos Jr. is eyeing...

PBBM appoints Francis Tolentino as new Acting Labor Secretary

By Dean Aubrey Caratiquet In a briefing on Monday, Presidential Communications Office (PCO) Undersecretary and Palace Press Officer Claire Castro announced the appointment of former...

PBBM’s ECP Program leads to promotion of over 1.5K teachers, school heads in Caraga

By Dean Aubrey Caratiquet Consistent with the government’s push to uplift the education sector, a total of 1,559 teachers and school heads across the Caraga...

PBBM ensures support for athletes in 2026 Palarong Pambansa

By Dean Aubrey Caratiquet Reinforcing the government’s belief in the capabilities of Filipino athletes in various sports, President Ferdinand R. Marcos Jr. reassured young participants...